Paper8109941
Immunological effects of amphotericin B and liposomal amphotericin B on splenocytes from immune-normal and immune-compromised mice.
Schindler JJ and 3 others. Antimicrob Agents Chemother, 1993. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Immunological effects of amphotericin B and liposomal amphotericin B on splenocytes from immune-normal and immune-compromised mice. Papers, record 8109941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8109941
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunological effects of amphotericin B and liposomal amphotericin B on splenocytes from immune-normal and immune-compromised mice.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amphotericin B | Major topic |
| B-Lymphocytes | Major topic |
| Spleen | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Cell Survival | |
| Cyclophosphamide | |
| Cyclosporine | |
| Dose-Response Relationship, Drug | |
| Drug Carriers | |
| Female | |
| Immunosuppressive Agents | |
| Liposomes | |
| Lymphocyte Activation | |
| Mice | |
| Mice, Inbred BALB C | |
| Mitogens | |
| Sensitivity and Specificity | |
| Stimulation, Chemical |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5672005 | The interaction of polyene antibiotics with thin lipid membranes. | J Gen Physiol | 1968 | https://conductscience.org/library/papers/5672005 | PubMed |
| 2 | 5514157 | The ion permeability induced in thin lipid membranes by the polyene antibiotics nystatin and amphotericin B. | J Gen Physiol | 1970 | https://conductscience.org/library/papers/5514157 | PubMed |
| 3 | 302761 | Augmentation of murine immune responses by amphotericin B. | Cell Immunol | 1977 | https://conductscience.org/library/papers/302761 | PubMed |
| 4 | 6842027 | Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. | J Infect Dis | 1983 | https://conductscience.org/library/papers/6842027 | PubMed |
| 5 | 6696909 | Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. | Biochim Biophys Acta | 1984 | https://conductscience.org/library/papers/6696909 | PubMed |
| 6 | 1848451 | Phase behaviour of amphotericin B multilamellar vesicles. | Biochim Biophys Acta | 1991 | https://conductscience.org/library/papers/1848451 | PubMed |
| 7 | 2578433 | Effect of liposomal amphotericin B on murine macrophages and lymphocytes. | Infect Immun | 1985 | https://conductscience.org/library/papers/2578433 | PubMed |
| 8 | 3457021 | Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro. | J Clin Invest | 1986 | https://conductscience.org/library/papers/3457021 | PubMed |
| 9 | 3733533 | Involvement of host macrophages in the immunoadjuvant activity of amphotericin B in a mouse fungal infection model. | J Antibiot (Tokyo) | 1986 | https://conductscience.org/library/papers/3733533 | PubMed |
| 10 | 3413081 | Unusual lipid structures selectively reduce the toxicity of amphotericin B. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/3413081 | PubMed |
| 11 | 2640154 | Activity of cyclosporin A and a non-immunosuppressive cyclosporin against multidrug resistant leukemic cell lines. | Cancer Commun | 1989 | https://conductscience.org/library/papers/2640154 | PubMed |
| 12 | 6721469 | Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6721469 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31976381 | Tissue-specific transcriptomic changes associated with AmBisome® treatment of BALB/c mice with experimental visceral leishmaniasis. | Wellcome Open Res | 2019 | https://conductscience.org/library/papers/31976381 | PubMed |
| 17722276 | Optimizing efficacy of amphotericin B through nanomodification. | Int J Nanomedicine | 2006 | https://conductscience.org/library/papers/17722276 | PubMed |
| 12760853 | Voriconazole inhibits fungal growth without impairing antigen presentation or T-cell activation. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/12760853 | PubMed |
| 11451704 | Influence of liposomal amphotericin B on CD8 T-cell function. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11451704 | PubMed |
| 9561346 | Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis. | Drugs | 1998 | https://conductscience.org/library/papers/9561346 | PubMed |
| 8894350 | Carrier effects on biological activity of amphotericin B. | Clin Microbiol Rev | 1996 | https://conductscience.org/library/papers/8894350 | PubMed |
| 8875279 | Immunomodulating effects of antibiotics: literature review. | Infection | 1996 | https://conductscience.org/library/papers/8875279 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8109941
GET https://conductscience.org/api/papers/v1/8109941/authors